Growing market for pain-related medical devices: what anesthesia and pain providers can learn from the Open Payments Database

With great interest, we have been following the notable growth in the acute and chronic pain markets on an industry level. Advancements like neuromodulation and new regional techniques for opioid-sparing analgesia, alongside shifts toward ambulatory surgery and rising chronic illness, continue to engage anesthesia and pain providers in industry efforts.1 Paralleling this growth, legislative efforts have encouraged greater financial transparency between physicians and industry, like the Physician Sunshine Act of 2010. The Centers for Medicare & Medicaid Services’ publicly available Open Payments Database (OPD) provides valuable insights into where monetary value is directed from industry within the field of anesthesiology and pain medicine, and where potential growth opportunities lie.2